Psilocybin
Psilocybin is a chemical substance. It can cause hallucinations when eaten, and has also been found to reverse psychological conditioning, grow brain cells and heal the brain.[2] It occurs in many kinds of fungi and mushrooms, most notably Psilocybin mushrooms. Most of these are known as psychedelic mushrooms. It grows in Europe, South America, Mexico, and the United States. Mushrooms that contain psilocybin are known as magic mushrooms.
The substance is used as a recreational drug. It is illegal in many countries.
Psilocybin works by activating serotonin receptors, most often in the prefrontal cortex. This part of the brain affects mood, cognition, and perception. Hallucinogens also work in other regions of the brain that regulate arousal and panic responses.[3]
The hallucinogenic effects of psilocybin usually occur within 30 minutes after a person ingests it and last 4–6 hours. In some individuals, changes in sensory perception and thought patterns can last for several days.
In 2016, Johns Hopkins Medicine researchers first reported that treatment with psilocybin under psychologically supported conditions significantly relieved existential anxiety and depression in people.[4][5]
Psilocybin Media
American psychologist and counterculture figure Timothy Leary conducted early experiments into the effects of psychedelic drugs, including psilocybin (1989 photo).
The ability of psilocybin to cause perceptual distortions is linked to its influence on the activity of the prefrontal cortex.
Chart of dependence potential and effective dose/lethal dose ratio of several psychoactive drugs.
Theoretical intramolecular hydrogen bond and pseudo-ring system occurring with psilocin (4-HO-DMT) but not with bufotenin (5-HO-DMT).
Metabolism of psilocybin and psilocin in humans and mice.
The neurotransmitter serotonin is structurally similar to psilocybin.
Biosynthetic route previously thought to lead to psilocybin. It has recently been shown that 4-hydroxylation and O-phosphorylation immediately follow decarboxylation, and neither dimethyltryptamine nor psilocin are intermediates, although spontaneously generated psilocin can be converted back to psilocybin.
References
- ↑ Geiger, Haden A.. DARK Classics in Chemical Neuroscience: Psilocybin. ACS Chem. Neurosci. 9 (10) (2018). p. 2438–2447. doi:10.1021/acschemneuro.8b00186. Retrieved 15 January 2024.
- ↑ Catlow, Briony J.. Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. Experimental Brain Research 228 (4) (June 2, 2013)Springer. p. 481–491. doi:10.1007/s00221-013-3579-0. Retrieved January 16, 2023.
- ↑ What are magic mushrooms and psilocybin? (October 3, 2021)MedicalNewsToday. Retrieved January 16, 2023.
- ↑ Hallucinogenic Drug Psilocybin Eases Existential Anxiety in People With Life-Threatening Cancer (December 2, 2016)Johns Hopkins Medicine. Retrieved January 16, 2023.
- ↑ Griffiths, Roland R.. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England) 30 (12) (December 2016)National Library of Medicine. p. 1181–1197. doi:10.1177/0269881116675513.